Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://primetherapeutics.com/w/how-prime-therapeutics-identifies-and-investigates-fraud-waste-and-abuse-in-health-care Example Link

Perspectives, Technology

How Prime Therapeutics identifies and investigates fraud, waste and abuse in health care

April 08, 2025

https://primetherapeutics.com/w/fda-decisions-expected-may-2025 /fda-decisions-expected-may-2025

Research & Publications

FDA Decisions Expected: May 2025

April 14, 2025

https://primetherapeutics.com/w/oncology-insights-april-2025 /oncology-insights-april-2025

Research & Publications

Oncology Insights: April 2025

April 14, 2025

https://primetherapeutics.com/w/specialty-pharmacy-continuum-do-glp-1-stoppages-warrant-a-relook-from-pbms-payors- https://www.specialtypharmacycontinuum.com/Clinical/Article/04-25/GLP-1-Agonist-Persistence-Study/76809

In the News

Specialty Pharmacy Continuum: Do GLP-1 Stoppages Warrant A Relook From PBMs, Payors?

April 11, 2025

The Latest

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-therapeutics-highlights-industry-leading-glp-1-research-at-amcp-2025

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

March 31, 2025

https://primetherapeutics.com/w/prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

October 24, 2024

https://primetherapeutics.com/w/medical-benefit-drug-trend-prime-therapeutics-medical-pharmacy-trend-report-goes-behind-the-numbers-2024

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

October 15, 2024

https://primetherapeutics.com/w/prime-therapeutics-bolsters-its-position-as-industry-leader-with-10-research-studies-at-amcp-nexus-2024

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

October 10, 2024

https://primetherapeutics.com/w/prime-therapeutics-announces-new-cost-effective-humira-biosimilar-solutions-offering-clients-flexibility-and-choice

Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice

October 07, 2024

https://primetherapeutics.com/w/prime-therapeutics-llc-earns-certification-from-the-national-committee-for-quality-assurance

Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance

October 03, 2024

Showing 1 to 6 of 35

Categories

PA Sub-Categories

https://primetherapeutics.com/w/how-prime-therapeutics-identifies-and-investigates-fraud-waste-and-abuse-in-health-care

How Prime Therapeutics identifies and investigates fraud, waste and abuse in health care

April 08, 2025

https://primetherapeutics.com/w/how-the-medicare-member-drug-cost-predictive-model-can-forecast-medicare-part-d-drug-costs

How the Medicare Member Drug Cost Predictive Model can forecast Medicare Part D drug costs

April 02, 2025

https://primetherapeutics.com/w/prime-therapeutics-glp-1-research-at-amcp-offers-additional-perspectives-to-obesity-treatment

Prime Therapeutics GLP-1 research at AMCP offers additional perspectives to obesity treatment

April 01, 2025

https://primetherapeutics.com/w/counterfeit-glp-1s-what-to-watch-out-for

Counterfeit GLP-1s: What to watch out for

November 18, 2024

https://primetherapeutics.com/w/amcp-nexus-in-focus-exploring-prime-s-glp-1-research-in-depth

AMCP Nexus in focus: Exploring Prime’s GLP-1 research in depth

November 04, 2024

https://primetherapeutics.com/w/taking-a-closer-look-at-prime-s-glp-1-year-2-cost-of-care-findings

Taking a closer look at Prime’s GLP-1 Year-2 cost-of-care findings

October 30, 2024

Showing 1 to 6 of 51

Categories

PA Sub-Categories

https://primetherapeutics.com/w/pharmacy-residency-program-offers-opportunities-to-present-real-world-research-at-amcp-2025

Pharmacy residency program offers opportunities to present real-world research at AMCP 2025

April 11, 2025

https://primetherapeutics.com/w/prime-therapeutics-honored-with-jmcp-article-of-the-year-award-for-excellence

Prime Therapeutics honored with JMCP “Article of the Year” Award for Excellence

April 10, 2025

https://primetherapeutics.com/w/listen-now-decoding-health-outcomes-at-amcp-annual-meeting-2025

LISTEN NOW: Decoding health outcomes at AMCP Annual Meeting 2025

April 07, 2025

https://primetherapeutics.com/w/prime-together-foundation-advances-equity-justice-with-grants-to-22-nonprofit-organizations

Prime Together Foundation advances equity, justice with grants to 22 nonprofit organizations

April 03, 2025

https://primetherapeutics.com/w/recap-academy-of-managed-care-pharmacy-amcp-annual-meeting-2025

RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2025

April 02, 2025

https://primetherapeutics.com/w/look-for-prime-therapeutics-at-amcp-2025

Look for Prime Therapeutics at AMCP 2025

March 31, 2025

Showing 1 to 6 of 107

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

https://primetherapeutics.com/w/prime-presents-2024-medical-pharmacy-trend-report-webinar

Prime presents 2024 Medical Pharmacy Trend Report webinar on Oct. 24

October 01, 2024

https://primetherapeutics.com/w/prime-presents-at-amcp-nexus-2024

Prime presents at AMCP Nexus 2024 on Oct. 14–17

September 30, 2024

https://primetherapeutics.com/w/prime-presents-at-medicaid-drug-rebate-program-mdrp-summit-2024-on-sept-23-25

Prime presents at Medicaid Drug Rebate Program (MDRP) Summit 2024 on Sept. 23–25

September 23, 2024

https://primetherapeutics.com/w/prime-presents-at-72nd-annual-roy-a-bowers-conference

Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22

September 16, 2024

https://primetherapeutics.com/w/prime-presents-at-glp-1-agonists-food-is-medicine-a-new-recipe-for-success-in-treating-obesity-a-briefing-for-congress-

Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11

September 11, 2024

Showing 1 to 6 of 33

Categories

PA Sub-Categories

Specialty Pharmacy Continuum: Do GLP-1 Stoppages Warrant A Relook From PBMs, Payors?

April 11, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-what-s-ahead-for-site-neutral-payments-in-medicare-and-state-policies-amcp-annual-2025

Managed Healthcare Executive: What's Ahead for Site-Neutral Payments in Medicare and State Policies | AMCP Annual 2025

April 02, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-protecting-patient-access-amid-site-of-service-policy-changes-amcp-annual-2025 https://www.managedhealthcareexecutive.com/view/protecting-patient-access-amid-site-of-service-policy-changes-amcp-annual-2025

Managed Healthcare Executive: Protecting Patient Access Amid Site of Service Policy Changes | AMCP Annual 2025

April 02, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-the-impact-of-site-neutral-payment-on-healthcare-costs-patient-access-amcp-annual-2025 https://www.managedhealthcareexecutive.com/view/the-impact-of-site-neutral-payment-on-healthcare-costs-patient-access-amcp-annual-2025

Managed Healthcare Executive: The Impact of Site-Neutral Payment on Healthcare Costs, Patient Access | AMCP Annual 2025

April 02, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-prime-therapeutics-finds-no-medical-cost-offsets-for-glp-1-obesity-drugs-amcp-annual-2025 https://www.managedhealthcareexecutive.com/view/prime-therapeutics-finds-no-medical-cost-offsets-for-glp-1-obesity-drugs-amcp-annual-2025

Managed Healthcare Executive: Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025

April 01, 2025

https://primetherapeutics.com/w/at-current-prices-glp-1s-aren-t-cost-effective-limiting-access-to-patients https://www.forbes.com/sites/joshuacohen/2025/03/17/at-current-prices-glp-1s-arent-cost-effective-limiting-access-to-patients/

Forbes: At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients

March 17, 2025

Showing 1 to 6 of 100

Categories

PA Research & Publications

https://primetherapeutics.com/w/fda-decisions-expected-may-2025 /fda-decisions-expected-may-2025

FDA Decisions Expected: May 2025

April 14, 2025

https://primetherapeutics.com/w/oncology-insights-april-2025 /oncology-insights-april-2025

Oncology Insights: April 2025

April 14, 2025

https://primetherapeutics.com/w/prime-therapeutics-presents-seven-research-posters-at-amcp-annual-meeting-2025-1 https://www.primetherapeutics.com/amcp-annual-2025-pdfs

Prime Therapeutics presents seven research posters at AMCP Annual Meeting 2025

March 31, 2025

https://primetherapeutics.com/w/clinical-highlights-march-2025 /clinical-highlights-march-2025

Clinical Highlights: March 2025

March 27, 2025

https://primetherapeutics.com/w/drug-approvals-march-2025 /drug-approvals-march-2025

Drug Approvals: March 2025

March 26, 2025

https://primetherapeutics.com/w/2025-spring-prime-therapeutics-report /spring-2025-prime-therapeutics-report

Spring 2025 Prime Therapeutics Report

March 21, 2025

Showing 1 to 6 of 138

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Careers

Careers Overview

Read - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

How Prime Therapeutics identifies and investigates fraud, waste and abuse in health care

FDA Decisions Expected: May 2025

Oncology Insights: April 2025

Specialty Pharmacy Continuum: Do GLP-1 Stoppages Warrant A Relook From PBMs, Payors?

The Latest

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice

Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance

How Prime Therapeutics identifies and investigates fraud, waste and abuse in health care

How the Medicare Member Drug Cost Predictive Model can forecast Medicare Part D drug costs

Prime Therapeutics GLP-1 research at AMCP offers additional perspectives to obesity treatment

Counterfeit GLP-1s: What to watch out for

AMCP Nexus in focus: Exploring Prime’s GLP-1 research in depth

Taking a closer look at Prime’s GLP-1 Year-2 cost-of-care findings

Pharmacy residency program offers opportunities to present real-world research at AMCP 2025

Prime Therapeutics honored with JMCP “Article of the Year” Award for Excellence

LISTEN NOW: Decoding health outcomes at AMCP Annual Meeting 2025

Prime Together Foundation advances equity, justice with grants to 22 nonprofit organizations

RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2025

Look for Prime Therapeutics at AMCP 2025

Prime presents at ISG Digital Business Summit on Nov. 14

Prime presents 2024 Medical Pharmacy Trend Report webinar on Oct. 24

Prime presents at AMCP Nexus 2024 on Oct. 14–17

Prime presents at Medicaid Drug Rebate Program (MDRP) Summit 2024 on Sept. 23–25

Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22

Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11

Specialty Pharmacy Continuum: Do GLP-1 Stoppages Warrant A Relook From PBMs, Payors?

Managed Healthcare Executive: What's Ahead for Site-Neutral Payments in Medicare and State Policies | AMCP Annual 2025

Managed Healthcare Executive: Protecting Patient Access Amid Site of Service Policy Changes | AMCP Annual 2025

Managed Healthcare Executive: The Impact of Site-Neutral Payment on Healthcare Costs, Patient Access | AMCP Annual 2025

Managed Healthcare Executive: Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025

Forbes: At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients

FDA Decisions Expected: May 2025

Oncology Insights: April 2025

Prime Therapeutics presents seven research posters at AMCP Annual Meeting 2025

Clinical Highlights: March 2025

Drug Approvals: March 2025

Spring 2025 Prime Therapeutics Report

Login Portals

Compliance / Legal

Careers